Zai Lab
IPOPublic · Shanghai, China · Founded 2014 · $130.0M raised
- Headquarters
- Shanghai
- Employees
- 1001–5000
- Founded
- 2014
- Business Model
- B2B
- Website
- zailaboratory.com
- Total Funding
- $130.0M
- Last Round
- $100.0M Series BJun 2016
- Rounds
- 2
- Type
- Public
About
Zai Lab is a patient-focused, commercial-stage global biopharmaceutical company founded in 2014, based in China and the United States. It discovers, develops, and commercializes therapies in oncology, immunology, neuroscience, and infectious disease, with eight products on the market in China.
Summary
Zai Lab is a Biotech company based in Shanghai, China, founded in 2014. It has raised $130.0M in total across 2 rounds, most recently a $100.0M Series B round in Jun 2016.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2017
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.